Results for tag: "Diabetic Nephropathy Drug"

Diabetic Nephropathy is a type of kidney disease caused by diabetes. It is a major complication of diabetes and is the leading cause of end-stage renal disease. Endocrine and Metabolic Disorders Drugs are used to treat this condition. These drugs are used to reduce the risk of kidney damage, control blood sugar levels, and reduce the risk of cardiovascular disease. Commonly used drugs include ACE inhibitors, angiotensin receptor blockers, diuretics, and statins. Other drugs used to treat diabetic nephropathy include calcium channel blockers, alpha-glucosidase inhibitors, and insulin sensitizers. The Diabetic Nephropathy Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Novartis, Merck, Pfizer, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Other companies in the market include Eli Lilly, GlaxoSmithKline, Boehringer Ingelheim, and Takeda Pharmaceuticals. Show Less Read more